LCN2 and breast cancer: Overexpression of LCN2 in breast cancer, accompanied by increased expression of the key EMT transcription factor Slug, upregulated the mesenchymal markers vimentin and fibronectin while downregulated the epithelial marker E-cadherin, increasing the invasiveness of the tumor.